InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Edesa Biotech, Inc.

EDSA Clue Score49
British Columbia, Canada Fiscal year ends September CIK 0001540159
$3.51 -4.10% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.51 −54.18% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue0.2Operating income−5.2Net income−5.0Fiscal year 2018Revenue0.2 −7.2%Operating income−5.1Net income−5.0Fiscal year 2018Revenue0.0 −100.0%Operating income−1.6Net income−1.5Fiscal year 2020Revenue0.3Operating income−6.4Net income−6.4Fiscal year 2021Revenue0.0 −100.0%Operating income−23.7Net income−13.3Fiscal year 2022Operating income−18.4Net income−17.5Fiscal year 2023Operating income−9.2Net income−8.4Fiscal year 2024Operating income−7.0Net income−6.2Fiscal year 2025Operating income−7.9Net income−7.2
FY2017FY2018FY2018FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.2 0.2 0.0 0.3 0.0 n/a n/a n/a n/a
Growth −7.2% −100.0% −100.0%
Operating income −5.2 −5.1 −1.6 −6.4 −23.7 −18.4 −9.2 −7.0 −7.9
Net income −5.0 −5.0 −1.5 −6.4 −13.3 −17.5 −8.4 −6.2 −7.2
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−2,288.6%Net margin−2,203.7%Free cash flow margin−2,191.3%Fiscal year 2018Operating margin−2,397.1%Net margin−2,378.6%Free cash flow margin−2,359.4%Fiscal year 2018Fiscal year 2020Operating margin−1,946.7%Net margin−1,935.3%Free cash flow margin−1,518.0%Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2017FY2018FY2018FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −2,288.6% −2,397.1% n/a −1,946.7% n/a n/a n/a n/a n/a
Net margin −2,203.7% −2,378.6% n/a −1,935.3% n/a n/a n/a n/a n/a
Free cash flow margin −2,191.3% −2,359.4% n/a −1,518.0% n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−4.7Capital expenditure−0.3Free cash flow−5.0Fiscal year 2018Operating cash flow−4.6Capital expenditure−0.4Free cash flow−5.0Fiscal year 2018Operating cash flow−1.3Capital expenditure−0.0Free cash flow−1.3Fiscal year 2020Operating cash flow−5.0Capital expenditure−0.0Free cash flow−5.0Fiscal year 2021Operating cash flow−13.7Capital expenditure−0.0Free cash flow−13.7Fiscal year 2022Operating cash flow−12.3Capital expenditure−0.0Free cash flow−12.3Fiscal year 2023Operating cash flow−6.6Capital expenditure0.0Free cash flow−6.6Fiscal year 2024Operating cash flow−4.9Fiscal year 2025Operating cash flow−7.3
FY2017FY2018FY2018FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −4.7 −4.6 −1.3 −5.0 −13.7 −12.3 −6.6 −4.9 −7.3
Capital expenditure −0.3 −0.4 −0.0 −0.0 −0.0 −0.0 0.0 n/a n/a
Free cash flow −5.0 −5.0 −1.3 −5.0 −13.7 −12.3 −6.6 n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash4.6Shareholders’ equity7.4Fiscal year 2018Cash4.2Shareholders’ equity11.3Fiscal year 2018Cash3.4Shareholders’ equity3.2Fiscal year 2020Cash7.2Shareholders’ equity6.6Fiscal year 2021Cash7.8Shareholders’ equity13.1Fiscal year 2022Cash7.1Shareholders’ equity9.4Fiscal year 2023Cash5.4Shareholders’ equity7.0Fiscal year 2024Cash1.0Shareholders’ equity2.0Fiscal year 2025Cash10.8Shareholders’ equity12.5
FY2017FY2018FY2018FY2020FY2021FY2022FY2023FY2024FY2025
Cash 4.6 4.2 3.4 7.2 7.8 7.1 5.4 1.0 10.8
Shareholders’ equity 7.4 11.3 3.2 6.6 13.1 9.4 7.0 2.0 12.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending September, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Sep 2017 FY2018 30 Sep 2018 FY2018 31 Dec 2018 FY2020 30 Sep 2020 FY2021 30 Sep 2021 FY2022 30 Sep 2022 FY2023 30 Sep 2023 FY2024 30 Sep 2024 FY2025 30 Sep 2025
Operations
−4.7 −4.6 −1.3 −5.0 −13.7 −12.3 −6.6 −4.9 −7.3
Growth
0.2 n/a n/a n/a n/a n/a 0.2 0.2 0.1
Investment
−0.3 −0.4 −0.0 −0.0 −0.0 −0.0 0.0 n/a n/a
calc −5.0 −5.0 −1.3 −5.0 −13.7 −12.3 −6.6 n/a n/a
Growth
1.7 −4.5 −0.0 0.0 −0.0 −0.0 0.0 n/a n/a
Financing
0.0 8.8 n/a 7.1 14.2 11.6 4.8 0.6 17.0

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.